<DOC>
	<DOCNO>NCT01888718</DOCNO>
	<brief_summary>To assess bioequivalence Fexofenadine Hydrochloride Orally Disintegrating Tablets 30 mg Dr. Reddy 's Laboratories Limited , India compare Allegra® ( contain fexofenadine hydrochloride ) Orally Disintegrating Tablets 30 mg Sanofi - aventis U.S. LLC , Bridgewater , NJ 08807 healthy , adult , human subject fast condition . To monitor adverse event ensure safety subject .</brief_summary>
	<brief_title>Bioequivalence Study Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition</brief_title>
	<detailed_description>An open Label , Balanced , Randomized , Two-treatment , Two-period , Two-sequence , Single Dose , Crossover , Oral Bioequivalence Study Fexofenadine Hydrochloride Orally Disintegrating Tablets 30 mg Dr. Reddy 's Laboratories Limited , India Comparing With That Allegra ® ( Containing Fexofenadine Hydrochloride ) Orally Disintegrating Tablets 30 mg Sanofi - Aventis U.S. LLC , Bridgewater , NJ 08807 Healthy , Adult , Human Subjects Under Fasting Conditions .</detailed_description>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<criteria>. Provide write informed consent . ii . Must healthy , adult , human being within 18 45 year age ( inclusive ) weigh least 50 kg . iii . Having body mass index 18.5 24.9 ( inclusive ) , calculate weight Kg/height m2 . iv . Must normal health determine medical history , physical examination laboratory investigation perform within 28 day prior commencement study . ( Laboratory value must within normal limit consider physician / investigator clinical significance ) . v. Female Subjects child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) Exclusion Criteria i.Incapable understanding inform consent . ii . Systolic blood pressure le 90 mm Hg 140 mm Hg . iii . Diastolic blood pressure le 60 mm Hg 90 mm Hg . iv . Oral temperature 95.0°F 98.6°F . v. Pulse rate 50/min 100/min . vi . History hypersensitivity idiosyncratic reaction investigational drug product relate drug . vii . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . viii . Consumption grapefruit past ten day prior checkin , period . ix . Regular smoker habit smoke nine cigarette per day difficulty abstain smoke sample collection period . x . Habit tobacco chew . xi . Habit alcoholism difficulty abstain alcohol sample collection period . xii . Difficulty abstain xanthine contain food beverage ( like tea , coffee , chocolates cola drink ) sample collection period . xiii . Intake counter ( OTC ) prescribe medication enzyme modify medication systemic medication last 30 day dose . xiv . Clinically significant abnormality / significant disease . xv . Confirmed positive alcohol screening . xvi . Confirmed positive select drug abuse . xvii . Participated clinical investigation use experimental drug/donated blood past 90 day date start study . xviii . Confirmed positive urine pregnancy test . xix . Female detect pregnant , breast feeding likely become pregnant study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>